Sergio Alejandro Lavandero González

Title: Innovations by Sergio Alejandro Lavandero González

Introduction

Sergio Alejandro Lavandero González is a notable inventor based in Santiago, Chile. He has made significant contributions to the field of medicine, particularly in the development of treatments for hypertension and cardiovascular diseases. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Sergio's latest patents include the use of the angiotensin-(1-9) peptide or its derivatives for preparing medicaments aimed at preventing, reverting, inhibiting, and/or reducing hypertension and inducing vasodilation. This invention focuses on the use of a vector that overexpresses the ACE2 enzyme, which is crucial for elevating the concentration of angiotensin-(1-9) in the blood and tissues. The vector can be an adenovirus, retrovirus, lentivirus, or adeno-associated virus containing the gene encoding for ACE2. Additionally, his pharmaceutical compositions are designed to treat cardiovascular, pulmonary, cerebral, and renal remodeling, providing effective methods for inhibiting and reducing cardiovascular remodeling.

Career Highlights

Sergio has worked with prestigious institutions such as Universidad de Chile and Pontificia Universidad Católica de Chile. His research and innovations have garnered attention in the medical community, showcasing his dedication to advancing healthcare solutions.

Collaborations

Some of his notable coworkers include Jorge Emilio Jalil Milad and Mario Martin Chiong Lay. Their collaborative efforts have contributed to the success of his research and inventions.

Conclusion

Sergio Alejandro Lavandero González is a prominent inventor whose work in hypertension treatment and cardiovascular health demonstrates the importance of innovation in medicine. His contributions are paving the way for new therapeutic approaches that could benefit many patients.